BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 35953586)

  • 21. Distinct gene expression program dynamics during erythropoiesis from human induced pluripotent stem cells compared with adult and cord blood progenitors.
    Merryweather-Clarke AT; Tipping AJ; Lamikanra AA; Fa R; Abu-Jamous B; Tsang HP; Carpenter L; Robson KJ; Nandi AK; Roberts DJ
    BMC Genomics; 2016 Oct; 17(1):817. PubMed ID: 27769165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Aberrant DNA Methylation Profile of Human Induced Pluripotent Stem Cells Is Connected to the Reprogramming Process and Is Normalized During In Vitro Culture.
    Tesarova L; Simara P; Stejskal S; Koutna I
    PLoS One; 2016; 11(6):e0157974. PubMed ID: 27336948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A selective cytotoxic adenovirus vector for concentration of pluripotent stem cells in human pluripotent stem cell-derived neural progenitor cells.
    Hirai T; Kono K; Sawada R; Kuroda T; Yasuda S; Matsuyama S; Matsuyama A; Koizumi N; Utoguchi N; Mizuguchi H; Sato Y
    Sci Rep; 2021 Jun; 11(1):11407. PubMed ID: 34075124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional characterization and expression profiling of human induced pluripotent stem cell- and embryonic stem cell-derived endothelial cells.
    Li Z; Hu S; Ghosh Z; Han Z; Wu JC
    Stem Cells Dev; 2011 Oct; 20(10):1701-10. PubMed ID: 21235328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strategies for rapidly mapping proviral integration sites and assessing cardiogenic potential of nascent human induced pluripotent stem cell clones.
    Dambrot C; Buermans HP; Varga E; Kosmidis G; Langenberg K; Casini S; Elliott DA; Dinnyes A; Atsma DE; Mummery CL; Braam SR; Davis RP
    Exp Cell Res; 2014 Oct; 327(2):297-306. PubMed ID: 24836851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of clinical-grade human induced pluripotent stem cells in Xeno-free conditions.
    Wang J; Hao J; Bai D; Gu Q; Han W; Wang L; Tan Y; Li X; Xue K; Han P; Liu Z; Jia Y; Wu J; Liu L; Wang L; Li W; Liu Z; Zhou Q
    Stem Cell Res Ther; 2015 Nov; 6():223. PubMed ID: 26564165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aurora-A overexpression is linked to development of aggressive teratomas derived from human iPS cells.
    Ohmine S; Salisbury JL; Ingle J; Pettinato G; Haddox CL; Haddad T; Galanis E; Ikeda Y; D'assoro AB
    Oncol Rep; 2018 Apr; 39(4):1725-1730. PubMed ID: 29393405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deriving Keratinocyte Progenitor Cells and Keratinocytes from Human-Induced Pluripotent Stem Cells.
    Ibrahim MR; Medhat W; El-Fakahany H; Abdel-Raouf H; Snyder EY
    Curr Protoc Stem Cell Biol; 2020 Sep; 54(1):e119. PubMed ID: 32744801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pluripotent Stem Cells to Model Degenerative Retinal Diseases: The RPE Perspective.
    Dalvi S; Galloway CA; Singh R
    Adv Exp Med Biol; 2019; 1186():1-31. PubMed ID: 31654384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative analysis of targeted differentiation of human induced pluripotent stem cells (hiPSCs) and human embryonic stem cells reveals variability associated with incomplete transgene silencing in retrovirally derived hiPSC lines.
    Toivonen S; Ojala M; Hyysalo A; Ilmarinen T; Rajala K; Pekkanen-Mattila M; Äänismaa R; Lundin K; Palgi J; Weltner J; Trokovic R; Silvennoinen O; Skottman H; Narkilahti S; Aalto-Setälä K; Otonkoski T
    Stem Cells Transl Med; 2013 Feb; 2(2):83-93. PubMed ID: 23341440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of red blood cells from human induced pluripotent stem cells.
    Dias J; Gumenyuk M; Kang H; Vodyanik M; Yu J; Thomson JA; Slukvin II
    Stem Cells Dev; 2011 Sep; 20(9):1639-47. PubMed ID: 21434814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TALEN-mediated generation and genetic correction of disease-specific human induced pluripotent stem cells.
    Ramalingam S; Annaluru N; Kandavelou K; Chandrasegaran S
    Curr Gene Ther; 2014; 14(6):461-72. PubMed ID: 25245091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective Elimination of Human Induced Pluripotent Stem Cells Using Medium with High Concentration of L-Alanine.
    Nagashima T; Shimizu K; Matsumoto R; Honda H
    Sci Rep; 2018 Aug; 8(1):12427. PubMed ID: 30127448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and evaluation of a novel xeno-free culture medium for human-induced pluripotent stem cells.
    Hua Y; Yoshimochi K; Li J; Takekita K; Shimotsuma M; Li L; Qu X; Zhang J; Sawa Y; Liu L; Miyagawa S
    Stem Cell Res Ther; 2022 Jun; 13(1):223. PubMed ID: 35658933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumorigenicity-associated characteristics of human iPS cell lines.
    Yasuda S; Kusakawa S; Kuroda T; Miura T; Tano K; Takada N; Matsuyama S; Matsuyama A; Nasu M; Umezawa A; Hayakawa T; Tsutsumi H; Sato Y
    PLoS One; 2018; 13(10):e0205022. PubMed ID: 30286143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient-derived induced pluripotent stem cells with a
    Zhang H; Wu LZ; Liu ZY; Jin ZB
    World J Stem Cells; 2024 May; 16(5):512-524. PubMed ID: 38817331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of mitophagy in human iPSC-derived cardiomyocytes.
    Yang M; Fu JD; Zou J; Sridharan D; Zhao MT; Singh H; Krigman J; Khan M; Xin G; Sun N
    Autophagy; 2022 Oct; 18(10):2481-2494. PubMed ID: 35220905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Engraftment of human induced pluripotent stem cell-derived myogenic progenitors restores dystrophin in mice with duchenne muscular dystrophy.
    He R; Li H; Wang L; Li Y; Zhang Y; Chen M; Zhu Y; Zhang C
    Biol Res; 2020 May; 53(1):22. PubMed ID: 32430065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene expression profile in human induced pluripotent stem cells: Chondrogenic differentiation in vitro, part A.
    Suchorska WM; Augustyniak E; Richter M; Trzeciak T
    Mol Med Rep; 2017 May; 15(5):2387-2401. PubMed ID: 28447755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An atypical human induced pluripotent stem cell line with a complex, stable, and balanced genomic rearrangement including a large de novo 1q uniparental disomy.
    Steichen C; Maluenda J; Tosca L; Luce E; Pineau D; Dianat N; Hannoun Z; Tachdjian G; Melki J; Dubart-Kupperschmitt A
    Stem Cells Transl Med; 2015 Mar; 4(3):224-9. PubMed ID: 25650439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.